ArticleBMC cancer2020

Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).

Joseph Tintelnot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.